Nutex Health Shares Financial Updates and Repurchase Program
Nutex Health Inc., a leading integrated healthcare delivery system, recently shared its preliminary financial results for the second quarter. This disclosure included some exciting insights regarding a stock repurchase program that is expected to enhance shareholder value.
Delayed Filing of Financial Statements
The company announced a delay in filing its Form 10-Q for the period ending June 30, 2025. This delay is due to necessary non-cash accounting adjustments related to stock-based compensation for hospitals that are still under construction. However, it is crucial to note that these adjustments are expected to have no negative impact on the company's revenue, gross profit, liquidity, working capital, or patient visit numbers.
Preliminary Financial Results
Nutex Health shared select preliminary financial results for the second quarter preceding the required financial filings.
Three-Month Financial Overview
For the quarter ending June 30, 2025, Nutex Health reported a remarkable total revenue of $244.0 million, a staggering increase of 220.7% compared to the same period in the previous year, where revenue stood at $76.1 million. Notably, revenue from mature hospitals surged by 203.2% in 2025 compared to 2024.
Gross Profit and Visits
Gross profit for the same period reached $124.9 million, constituting 51.2% of total revenue, showcasing a significant jump from $22.6 million or 29.7% of total revenue the previous year. During this period, the total visits at the Hospital Division reached 45,573, an increase of 10.6% compared to 41,208 visits in 2024.
Six-Month Financial Overview
For the six months that concluded on June 30, 2025, total revenue amounted to $455.8 million, marking an increase of 217.5% from $143.5 million in the same period of the prior year. This remarkable growth also included a gross profit of $243.3 million, or 53.4% of total revenue, an improvement over the previous year’s profit of $32.7 million.
Share Repurchase Program Details
The Board of Directors has authorized a stock repurchase program that allows for repurchases of up to $25 million of the company's common stock. This initiative aims to bolster shareholder value and offset potential dilution from future share issuances related to stock compensation obligations. Commencing upon the filing of the delayed financial report, this program will enable the company to acquire shares through various means, including open market transactions and privately negotiated deals.
About Nutex Health Inc.
Nutex Health, founded in 2011 and headquartered in Houston, Texas, is a dynamic healthcare management company. It operates through two divisions: the Hospital Division and the Population Health Management Division. The Hospital Division is responsible for owning and running micro-hospitals and specialty hospitals across multiple states, while the Population Health Management Division operates independent physician networks and offers management services to its affiliated entities.
Frequently Asked Questions
What is the recent financial performance of Nutex Health?
Nutex Health reported a total revenue of $244.0 million for the quarter ending June 30, 2025, significantly up from the previous year.
What adjustments led to the delayed financial filings?
The delay in filing was due to necessary non-cash accounting adjustments concerning stock-based compensation for under-construction hospitals.
How much is Nutex's stock repurchase program worth?
The board has authorized a stock repurchase program of up to $25 million over the next six months.
What are the expected outcomes of the stock repurchase?
The program aims to enhance shareholder value and mitigate dilution from future stock issuances.
What divisions does Nutex Health operate?
Nutex Health operates two divisions: a Hospital Division and a Population Health Management Division, providing a range of healthcare services.
